Linzagolix with and without concomitant add-back therapy was associated with reductions in heavy menstrual bleeding in uterine fibroids.
According to the Centers for Disease Control and Prevention ( CDC ), ovarian cancer may cause vaginal bleeding, pelvic pain, ...